BP000399-DEN-029: Recombinant Dengue Virus NS1 Subtype 1, Insect Cells
Source: Insect Cells-derived.
Purity > 95% pure as determined by 12.5% SDS-PAGE.BP000399-DEN-032: Recombinant Dengue Virus NS1 Subtype 4, Insect Cells
Source: Insect Cells-derived.
Purity > 95% pure as determined by 12.5% SDS-PAGE.BP002833-DEN-026: Recombinant Dengue Virus Subtype 2 & 4 fused Envelope 52 kDa, Suitable for Gold Conjugation
Source: E. coli-derived.
Purity > 95% pure as determined by 10% PAGE.BP002833-DEN-025: Recombinant Dengue Virus Subtype 1 & 4 fused Envelope 55 kDa, Suitable for Gold Conjugation
Source: E. coli-derived.
Purity > 95% pure as determined by 12% PAGE.BP002833-DEN-001: Recombinant Dengue Virus Subtype 1 & 3 fused Envelope 58 kDa, Suitable for Gold Conjugation
Source: E. coli-derived.
Purity > 95% pure as determined by 12% PAGE.BP002764-ENZ-211: Recombinant Human 2,4-Dienoyl CoA Reductase 2 (DECR2) Enzyme
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.BP001730-PRO-842: Recombinant Human Cytoglobin (CYGB) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP001930-PRO-1026: Recombinant Human Cytochrome B5 Reductase 3 (CYB5R3) Protein
Source: E. coli-derived.
Purity: > 95% as determined by SDS-PAGE.BP001712-CHM-337: Recombinant Mouse C-X-C Motif Chemokine 9 (CXCL9) Protein
Source: E. coli-derived.
The Activity is calculated by the ability to chemoattract Human lymphocytes using a concentration of 0.1-1 ng/ml corresponding to a Specific Activity of 1,000,000-10,000,000 IU/mg.
Purity: > 98% by RP-HPLC and SDS-PAGE.BP001712-CHM-333: Recombinant Human C-X-C Motif Chemokine 9 (CXCL9) Protein
Source: E. coli-derived.
Determined by its ability to chemoattract human peripheral blood T-Lymphocytes using a concentration range of 10-100 ng/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity: > 97% by RP-HPLC and SDS-PAGE.